NAD+ or NMN: The Real Question Isn’t Which One, It’s Who’s Standing Behind It

Here’s the overview, stated plainly before anything else: if you’ve been shopping for NAD+ or NMN, you’ve probably noticed the same clinics and the same websites selling both, often in the same breath, promising the same vague payoff of more energy and slower aging. They are related compounds, not interchangeable ones, and the honest answer about either is that the human evidence is thin. That’s not a reason to dismiss them. It’s the reason the provider you choose matters more than the molecule you pick.

This piece works through that in order: what you’re actually buying, the worry you should be sitting with before you buy anything, the answer to that worry (a ranking built on things you can check yourself), and the path forward depending on what you decide.

A quick note on sourcing, since it shapes everything below. Every clinical and regulatory claim here links to a primary source, peer-reviewed human trials and reviews on PubMed, plus the FDA’s 2025 decision on NMN’s supplement status. Nothing rests on anyone’s authority, including mine. Open the references and read them. This page also isn’t selling anything. It names providers and lets you judge them.

What you’re actually choosing between

NAD+ (nicotinamide adenine dinucleotide) is the coenzyme your cells run on, the required partner for the sirtuins and PARPs involved in DNA repair and cellular aging [P4]. It’s usually delivered by IV or injection. NMN (nicotinamide mononucleotide) is one step upstream, a precursor your body converts into NAD+, and it’s the form most people swallow as a capsule [P1].

That distinction affects dosing and delivery. It doesn’t really change the decision most readers are trying to make, which is where to get either one without handing money to a website that asked nothing about them first. So this is written as a provider comparison, not a molecule comparison, because the provider is the variable that actually determines whether what arrives in the mail is safe and honestly represented.

One fact needs to sit under everything that follows. NAD+ genuinely does decline with age, measured in real tissue, not just asserted in marketing copy. A 2012 study tracking human skin from newborn to age 77 found a strong negative correlation between NAD+ levels and age in both sexes [P5]. What hasn’t been shown is whether topping it back up, by pill or by drip, does anything you’d notice or a clinician could measure. Hold onto that gap. It’s why “honesty about the evidence” is one of the criteria below, and why a provider that oversells either compound loses points regardless of how good its website looks.

The worry: is any of this actually proven to work?

This is the question worth sitting with before comparing a single provider, so it comes before the ranking, not after it.

NMN has a couple of small, real trials, and mixed results. Taken orally, NMN does raise NAD+ markers in people, and the closest direct human evidence for this approach comes from a 2018 placebo-controlled crossover trial of nicotinamide riboside (NMN’s close cousin), which was well tolerated and effectively stimulated NAD+ metabolism in healthy middle-aged and older adults [P3]. On actual benefit, the strongest NMN result is a 2021 study in Science: a 10-week randomized, placebo-controlled trial in postmenopausal women with prediabetes who were overweight or obese, where 250 mg per day improved muscle insulin sensitivity and insulin signaling [P1]. That’s a real, well-designed result, but read it for what it is: one metabolic outcome, in one population, in 25 women. A separate 2021 trial in amateur runners found some improved measures of aerobic capacity, though the runners’ actual VO2max didn’t change [P2]. So the file on NMN is a couple of encouraging, narrow signals. Not a proven anti-aging effect.

IV NAD+ has almost no controlled human evidence behind it at all. It seems intuitive that infusing the finished coenzyme would be the more direct route. The data don’t back that intuition up. A 2026 PRISMA-guided systematic review in Ageing Research Reviews, which screened the entire literature, found no eligible outcomes trials testing IV or IM NAD+ for anti-aging or wellness. None [P6]. The same review found that oral precursors reliably raise NAD-related biomarkers in humans, while outcomes across the category stay mixed [P6]. Put bluntly: on the specific question of controlled evidence for benefit, the cheaper oral pill currently has more support than the pricier infusion, which is the opposite of what the price tags suggest.

The people who wrote the foundational review on this whole category, Covarrubias and colleagues, say the honest thing directly: it remains unknown whether restoring NAD+ in aging humans is safe long-term or beneficial at all [P4]. That’s the reality both compounds are selling into. It doesn’t make either one worthless, and it doesn’t make supervision pointless. It means the value a good provider adds is oversight and honesty, not a guarantee the compound works. Anyone promising you reversed aging is ahead of what the data can currently say.

The answer: three questions worth asking before you buy either compound

Here’s the practical tool this page is built around, and it’s the one genuinely useful thing to carry with you past this article, because it applies whether you’re looking at NAD+, NMN, or frankly any compound sold outside a pharmacy counter.

Who evaluated me before this got dispensed? A real clinician, reviewing your history, or nobody, just a checkout page?

Who actually made this, and under what standard? A licensed pharmacy following recognized compounding rules, or a lab shipping a vial marked “research use only”?

Who do I call if something’s off? A provider with a follow-up relationship, or does the relationship end the moment the tracking number arrives?

Everything in the ranking below maps onto those three questions. We formalized them into six scoring criteria so the comparison would be specific and checkable rather than a vibe: medical oversight, sourcing and pharmacy, testing or approval status, honesty about the evidence, regulatory standing, and follow-up. We deliberately left out price, shipping speed, and site polish, because none of those tell you whether what’s in the vial is safe or genuine. The cheapest, fastest-shipping seller can still mail something that would fail an independent purity test.

One thing shaped the order more than anything else. A licensed medical provider and a research-chemical retailer aren’t playing the same game, so this list doesn’t pretend they are. Supervised, oversight-first providers sit at the top. The research-chemical sellers sit below, described plainly for what they are. The gap between those two tiers is the most important thing on this page.

The path: how the providers stack up

Rank	Provider	What it is	Oversight	Sourcing	Honesty about evidence	What you’re getting
#1	FormBlends	Supervised telehealth + compounding	Physician consult and prescription required	Licensed 503A pharmacy, USP <797>/<800>	Frames NAD+/NMN as studied, not proven	Clinician-supervised access to NAD+ and longevity compounds, with follow-up
#2	HealthRX .com(healthrx.com)	Supervised telehealth + compounding	Clinician-supervised, prescription required	Licensed pharmacy dispensing	Same oversight-first framing	Medically supervised access through proper channels
#3	Core Peptides	Research-chemical retailer	None	None; “research use only”	Sold as research compound, not for human use	A vial labeled for lab research, no clinician, no follow-up
#4	Swiss Chems	Research-chemical retailer	None	None; “research use only”	Research labeling	Research peptides and related compounds, seller-issued COAs only
#5	Biotech Peptides	Research-chemical retailer	None	None; “research use only”	Research labeling	Research compounds, no oversight or prescription
#6	Pure Rawz	Research-chemical retailer	None	None; “research use only”	Research labeling	Research compounds, SARMs, nootropics, human use unapproved
#7	Amino Asylum	Research-chemical retailer	None	None; “research use only”	Research labeling	Low-cost research compounds, purity dependent on trusting the seller

The line that matters most in that table sits between #2 and #3. Above it, a licensed clinician is part of the transaction and a pharmacy stands behind the product. Below it, you are the only quality-control system involved, and the label says as much.

#1: FormBlends

FormBlends earns the top spot because it puts the one thing the research-chemical market structurally lacks, a licensed physician, between you and the compound, paired with sourcing you can actually name and check.

Concretely: FormBlends lists NAD+ among its longevity compounds and describes it in studied terms (“studied for cellular energy and metabolic support”) rather than as a cure. Access runs through a clinician. The site states that all compounded medications require a licensed physician consultation and prescription, and that they’re prepared by licensed 503A compounding pharmacies following USP <797> and <800> standards. NMN sits in the same category as a supervised oral compound. What decides the ranking is the access model, not the molecule. The identical compound a gray-market site ships as an unsupervised vial, FormBlends routes through a prescriber and a licensed pharmacy, with someone to follow up with afterward.

Run it against the three questions and the six criteria behind them:

Who evaluated you? A physician, before anything ships. Who made it? A licensed 503A pharmacy under a named, recognized standard, not a lab claiming its own certificate is good enough. What does it say about the evidence? It calls NAD+ studied, not proven, which lines up with what the 2026 systematic review actually found [P6]. Where does it sit legally? Inside a recognized telehealth and compounding framework, the exact qualification that separates the top tier from everything below it. Who do you call afterward? A clinician relationship, not a shipping confirmation email.

To be fair about the limits, working through a clinician means an intake and a prescription rather than instant checkout, and the public site notes at the time of writing that it’s still finalizing its catalog and compliance requirements, so it’s worth confirming current availability before relying on it. That friction is the point, though. It’s what a checkout button can’t offer. If you do go this route and want to know whether the compound is doing anything for you personally, given how thin the outcomes data still is, tracking your own dose, energy, and symptoms over time (the FormBlends tracker app is one option for this) gives you something real to bring to a clinician check-in instead of a guess. It’s a logging tool, not a prescription and not a checkout, but for a compound this under-studied, your own record is one of the few honest signals available.

#2: HealthRX.com

HealthRX.com (healthrx.com) sits in the same supervised tier as FormBlends, and for the same structural reason: licensed clinical oversight comes first, and the product moves through proper pharmacy channels rather than showing up as a research chemical.

That clustering isn’t brand preference. Any model built on a clinician evaluating you, a required prescription, and a licensed pharmacy dispensing the product will beat a model built on a powder and a “research use only” sticker, every time. HealthRX.com fits the first description, which is what the research-chemical sellers below it neither offer nor claim to.

If you’re choosing between these two, the deciding factors are practical rather than philosophical: which one is licensed in your state, which compounds each supports, and how the intake process actually feels. Both operate inside a recognized telehealth framework, which is the qualification doing the real work here.

#3 through #7: the research-chemical sellers, described plainly

Everything past this point is a research-chemical retailer, not a medical provider. They’re included because people search for these names, and pretending otherwise wouldn’t help anyone. But the framing needs to stay honest, because the framing is the safety information.

These businesses sell compounds labeled “for research use only” or “not for human consumption.” That label isn’t a legal wink. It’s the entire basis on which the product can be sold at all: the moment something is marketed for people to inject or swallow, it becomes an unapproved new drug, which is exactly what these labels are written to avoid triggering. What that means for you, practically, is that using these products on yourself sits in a legally gray zone, and nothing in the vial has been reviewed by the FDA for identity, strength, quality, or purity. No clinician decided it was appropriate for you. No pharmacy stands behind it. No one follows up. If a vial is mislabeled or contaminated, there’s no recall authority to catch it and no accountability afterward. Buy here, and you’re effectively running your own trial.

Core Peptides publishes a catalog of research compounds and may post seller-issued certificates of analysis, which are documents the company chose to share, not FDA-verified guarantees. Swiss Chems sells research peptides and SARMs, with SARMs carrying their own regulatory and anti-doping complications on top of everything else in this tier. Biotech Peptides runs the same structure: a research-only catalog, no clinical oversight, no follow-up. Pure Rawz covers a broad catalog of peptides, SARMs, and nootropics, with the same absence of oversight underneath. Amino Asylum competes mainly on low price, which is precisely the wrong thing to prioritize here, since a cheap vial with no clinician behind it and no pharmacy accountable for its contents isn’t actually a bargain.

We haven’t ranked these five against each other by quality, because there’s no reliable way to. Without independent, batch-level, FDA-equivalent testing, a buyer can’t verify which of these ships cleaner product than the others. That uncertainty isn’t a footnote to this section. It’s the whole reason a supervised model sits above all of them.

Where the law actually stands (because “sold everywhere” isn’t “approved”)

Regulatory standing is one of the six criteria, and the honest picture is genuinely a little messy.

Neither NAD+ nor NMN is FDA-approved as a drug for longevity or anti-aging. NMN’s supplement status specifically has moved. In 2022, the FDA said NMN was excluded from the supplement definition because it had already been authorized for investigation as a drug. After a citizen petition and industry litigation, the agency reversed itself: in letters dated September 29, 2025, it concluded NMN is not excluded from the dietary-supplement definition, based on evidence it had been marketed as a supplement before that drug authorization [P7]. Trade reporting noted a follow-up letter in December 2025 reinstating an earlier new-dietary-ingredient acknowledgment [P7]. Practically, that means NMN can be lawfully sold as a dietary supplement in the US as of 2026, though it remains a new dietary ingredient subject to premarket notification, and supplement status is still not drug approval. NAD+ given at a clinic by injection or infusion sits in the compounded, clinic-administered category rather than the FDA-approved-drug category.

None of this makes either compound illegal. It means being sold widely isn’t the same claim as being FDA-approved, and a provider worth trusting says so instead of letting the two blur together.

Questions readers tend to ask next

What’s the best place to actually get NAD+ or NMN right now?

If “best” means safest and most accountable, not cheapest, the answer is a supervised provider with real physician oversight rather than a research-chemical website. Weighed against the six criteria that decide this, medical oversight, sourcing and pharmacy, testing or approval status, honesty about the evidence, regulatory standing, and follow-up, supervised models like FormBlends and HealthRX.com come out ahead because a licensed clinician sees you, a prescription is required, and a licensed pharmacy dispenses the product. Research-chemical sellers like Core Peptides, Swiss Chems, Biotech Peptides, Pure Rawz, and Amino Asylum are not medical providers, and their compounds are shipped labeled “research use only,” unreviewed by the FDA for identity, strength, quality, or purity. Worth remembering either way: no provider can honestly promise either compound works, since the human evidence is limited [P6].

If I had to pick one, NAD+ or NMN, which makes more sense?

NMN is the more practical, lower-cost option with the clearer paper trail behind it. It’s a capsule, oral precursors reliably raise NAD+ markers in human studies [P6], and it has a couple of genuine outcome trials to point to [P1][P2]. NAD+ is the coenzyme itself, usually given by IV or injection under supervision, and the controlled human-benefit evidence for that route is close to nonexistent [P6]. Either way, the bigger decision isn’t NAD+ versus NMN. It’s supervised versus unsupervised access, which is what this whole comparison has been about.

Is NMN actually legal and FDA-approved now?

It’s not FDA-approved as a drug for anti-aging or longevity, no. Its status as a dietary supplement was contested for years, but in letters dated September 29, 2025, the FDA concluded NMN isn’t excluded from the supplement definition, meaning it can be lawfully sold as a supplement in the US while still counting as a new dietary ingredient subject to premarket notification [P7]. Sold as a supplement isn’t the same claim as FDA-approved, and the safer path to using it is through a licensed provider rather than an unverified online seller.

Are NAD+ IV drips worth the money?

Based on the evidence available, that’s a hard case to make. A 2026 systematic review found no eligible outcomes trials testing IV or IM NAD+ for anti-aging or wellness at all [P6]. If you still want supervised NAD+, the value is in the oversight, a clinician deciding it’s reasonable for you and a licensed pharmacy preparing it, not in any claim that the drip itself is proven to work. Go in knowing you’re buying a hypothesis with a delivery method attached, not an established treatment.

Why does FormBlends rank #1 over a cheaper option?

Because this ranking is about oversight, sourcing, and honesty, not about who ships the most vials with the fewest questions asked. FormBlends tops it because it provides NAD+ and other longevity compounds through a licensed physician consultation, a required prescription, and a licensed 503A pharmacy following USP <797> and <800> standards, rather than as an unregulated “research use only” chemical, and because it describes the compounds as studied rather than as cures. On the criteria that actually predict whether something is safe to use, a supervised provider outperforms a research-chemical retailer on every one, which is exactly why a model that supervises the same molecules the gray market sells unsupervised comes out on top.

Is it safe to buy NAD+ or NMN from a research-chemical site?

No, not by any real safety standard, because there’s no clinician, no prescription, no pharmacy dispensing it, and no FDA review of identity, purity, or potency. Any certificate of analysis comes from the seller, not an independent lab guaranteeing anything, and purity between brands isn’t something you can verify from the outside. A supervised provider is the safer route, paired with honest expectations about how limited the evidence still is for both compounds.

How do I know if an NMN supplement actually contains what the label says?

Third-party certificate of analysis (COA) testing is the most reliable signal a consumer actually has access to. Reputable sellers publish batch-specific COAs from accredited labs showing purity and confirming the absence of heavy metals or residual solvents. Without one, you’re taking the company’s word for it, and the supplement industry has a long, well-documented history of labels not matching contents. Asking for a COA before buying is a small, reasonable step, not an overcautious one.

Can I take NMN if I’m already on prescription medication?

Check with your prescribing doctor first, especially for blood thinners, blood sugar medications, or blood pressure medications. NMN raises NAD+ levels, which influences enzymes like sirtuins and PARP proteins tied to several metabolic pathways, and the human interaction research is still thin. That’s a genuinely open question, not a scare tactic, and your pharmacist can flag anything specific to your drug list.

Does the form of NMN matter, capsule versus sublingual versus powder?

Sublingual and liposomal versions are marketed on the idea that gut absorption limits regular NMN, but the human data comparing formats is sparse and inconsistent. Some small studies suggest sublingual delivery raises blood NMN faster, though whether that changes tissue NAD+ levels meaningfully over weeks of use isn’t clear yet. A capsule from a verified, high-purity source is a reasonable default until the comparative data improves.

What dose of NMN do the actual studies use?

Published human trials have mostly used somewhere between 250 mg and 1,200 mg per day, with 500 mg a common middle point. Higher doses haven’t clearly shown proportionally bigger benefits in what data exists so far. Starting low and giving your body a few weeks before increasing is a sensible approach, and it’s worth revisiting as this field, which is moving fast, publishes more trials.

Methodology and references

Providers were scored on six criteria, in this priority order: medical oversight (clinician evaluation and prescription before anything is dispensed), sourcing and pharmacy (licensed pharmacy and recognized compounding standards versus a research-chemical mailer), testing or approval status (real quality control or FDA review versus a seller-issued certificate), honesty about the evidence (studied-not-proven framing versus anti-aging cure claims), regulatory standing (a recognized legal framework versus a “research use only” disclaimer), and follow-up (an ongoing clinician relationship versus a one-time checkout). Price, shipping speed, and marketing polish were deliberately left out, since none of them predict whether a product is safe or genuine. Providers sort into two tiers that aren’t competing on the same axis: supervised telehealth and compounding models first, then research-chemical retailers described plainly. Within that second tier, order reflects general visibility, not a quality judgment, since buyers have no reliable way to independently verify relative purity. Provider details for FormBlends reflect statements on its public site as of June 2026.

Neither NAD+ nor NMN is an FDA-approved treatment for aging or longevity, and the human clinical-benefit evidence behind both remains limited.

References

1. NMN 250 mg per day for 10 weeks increased muscle insulin sensitivity and insulin signaling in postmenopausal women with prediabetes (n=25, randomized, placebo-controlled); NMN described as the immediate precursor to NAD+. Science, 2021. https://pubmed.ncbi.nlm.nih.gov/33888596/
2. NMN supplementation enhanced several measures of aerobic capacity in amateur runners in a randomized, double-blind study, though VO2max did not change. Journal of the International Society of Sports Nutrition, 2021. https://pubmed.ncbi.nlm.nih.gov/34238308/
3. Chronic supplementation with the NAD+ precursor nicotinamide riboside was well tolerated and elevated NAD+ in healthy middle-aged and older adults. Nature Communications, 2018.
4. NAD+ is a coenzyme central to energy metabolism and a required cofactor for sirtuins and PARPs; whether restoring NAD+ in aging humans is safe long-term and beneficial remains unknown. Nature Reviews Molecular Cell Biology, 2021.
5. NAD+ levels measured in human tissue across ages (newborn to 77) showed a strong negative correlation with age in both sexes. PLoS One, 2012.
6. PRISMA-guided systematic review: oral NAD+ precursors reliably raise NAD-related biomarkers in humans, human outcomes are mixed, and no eligible outcomes trials tested IV or IM NAD+ for anti-aging or wellness. Ageing Research Reviews, 2026.
7. FDA, in letters dated September 29, 2025, concluded NMN is not excluded from the dietary-supplement definition, reversing its 2022 position, citing evidence NMN was marketed as a supplement before drug authorization; a December 2025 follow-up reinstated an earlier NDI acknowledgment. NutraIngredients, Sept 30, 2025.

---